Resumen de Pharmacovigilance: Suspected adverse events, 2013
Increase in the number of reports of suspected adverse events in animals Fewer reports of human adverse events to veterinary medicines Notable increase in reports relating to products used for treating canine epilepsy These are some of the results from the surveillance work carried out by the pharmacovigilance unit at the Veterinary Medicines Directorate (VMD), as discussed by Giles Davis and colleagues from the VMD
